InvestorsHub Logo
Followers 80
Posts 1038
Boards Moderated 0
Alias Born 06/26/2014

Re: None

Friday, 12/13/2019 5:01:15 PM

Friday, December 13, 2019 5:01:15 PM

Post# of 424602
INDICATIONS AND USAGE------------------------------
VASCEPA is an ethyl ester of eicosapentaenoic acid (EPA) indicated:
• as an adjunct to maximally tolerated statin therapy to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable
angina requiring hospitalization in adult patients with elevated triglyceride (TG) levels (≥ 150 mg/dL) and
o established cardiovascular disease or
o diabetes mellitus and 2 or more additional risk factors
for cardiovascular disease. (1)

• as an adjunct to diet to reduce TG levels in adult patients with severe
(≥ 500 mg/dL) hypertriglyceridemia. (1) Limitations of Use:
• The effect of VASCEPA on the risk for pancreatitis in patients with severe
hypertriglyceridemia has not been determined. (1)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News